Every 8-K that Calumet, Inc. (CLMT) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow CLMT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CLMT filings page.
Calumet, Inc. (CLMT) entered into an Eleventh Amendment to its Third Amended and Restated Credit Agreement, increasing lender commitments from $500.0 million to $600.0 million, subject to borrowing base limitations. The amendment is among Calumet, Inc., Calumet Specialty Products Partners, L.P., certain subsidiaries, the lender group and Bank of America, N.A. as administrative agent.
In connection with this change, the company also executed a Fourth Amendment to the Monetization Master Agreement with J. Aron & Company LLC and related parties, which permits the increased commitments under the Credit Agreement. Both amendments are dated September 11, 2026 and are filed as exhibits.
Calumet, Inc. (CLMT) announced that subsidiary Montana Renewables, LLC amended its U.S. Department of Energy Loan Guarantee Agreement to reflect a smaller, more capital‑efficient expansion of its Great Falls renewable fuels facility. The expansion shifts from a large new‑build “Phase 2” project to a series of smaller scopes that primarily repurpose existing equipment.
The amendment reduces the guaranteed loan’s maximum principal to $815.8 million and the maximum capitalized interest to $232.8 million, and lowers the Base Cash Equity Reserve Account threshold from $80.0 million to $20.0 million. Montana Renewables targets an annual run rate of about 200 million gallons of Sustainable Aviation Fuel and 17,000 barrels per day of total renewable product sales by year‑end 2028. Remaining project capital is expected to be $137 million, down from the original $1.2 billion Phase 2 concept, with funding anticipated from MRL earnings plus a final $34 million DOE draw. The DOE loan remains split into a previously funded $782 million tranche and the final draw, carries a 15‑year tenor at the U.S. Treasury rate plus 3/8%, and defers principal and interest servicing until MaxSAF® is commissioned, with first servicing in March 2029 and maturity in December 2039.
Calumet, Inc. reported second quarter 2026 results showing higher revenue but continued losses. Sales were $1,445.1 million, with a net loss of $(95.9) million, or $(1.09) per share. Management highlighted that results were heavily affected by non-cash items, including a $9.0 million unrealized gain on derivatives and $163.6 million of non-cash RINs-related expense. EBITDA was $(30.3) million, while Adjusted EBITDA rose to $159.3 million, and Adjusted EBITDA with Tax Attributes reached $175.2 million, both significantly above the prior-year quarter.
The Specialty Products and Solutions segment generated $161.7 million of Adjusted EBITDA in the quarter, up from $66.8 million, reflecting a supportive margin environment. Performance Brands produced $6.3 million of Adjusted EBITDA versus $13.5 million a year earlier, while Montana/Renewables delivered $26.6 million of Adjusted EBITDA with Tax Attributes, up from $16.3 million, as the first phase of the MaxSAF® 150 expansion was completed. Deleveraging efforts continued after quarter-end with $115 million of debt retirement in July. As of June 30, 2026, total assets were $2,802.8 million, total liabilities were $3,689.3 million, the current RINs obligation was $480.2 million, and stockholders’ equity stood at $(1,137.1) million.
Calumet, Inc. reported voting results from its 2026 Annual Meeting of Stockholders held on June 2, 2026. Stockholders elected three Class II directors—Todd Borgmann, Daniel J. Sajkowski, and Bradford T. Sanders—to serve until the 2029 annual meeting.
Support for the director nominees ranged from 50,332,470 to 51,130,433 votes in favor, with 19,926,638 broker non-votes recorded for each nominee. Stockholders also approved, on a non-binding advisory basis, the Company’s executive compensation, with 50,222,235 votes for, 956,685 against, and 276,087 abstentions.
In addition, stockholders ratified the selection of Grant Thornton LLP as the independent registered public accounting firm for the year ending December 31, 2026, receiving 70,973,872 votes for, 194,987 against, and 212,786 abstentions.
Calumet, Inc. reported a much wider net loss for the first quarter of 2026 as non-cash RIN and derivative charges weighed on results. Net loss was $317.0 million versus $162.0 million a year earlier, with basic loss per share at $3.64 versus $1.87. Sales rose modestly to $1,029.7 million from $993.9 million, but cost of sales increased faster, driving a gross loss of $87.5 million.
Adjusted EBITDA declined to $27.6 million from $38.1 million, while Adjusted EBITDA with Tax Attributes was $50.1 million compared with $55.0 million. Management highlighted strong specialty and Performance Brands volumes but cited rapid feedstock cost increases and an unplanned Shreveport outage that cut about 750,000 barrels of production.
By segment, Specialty Products and Solutions Adjusted EBITDA fell to $44.3 million, Performance Brands to $12.6 million, while Montana/Renewables Adjusted EBITDA with Tax Attributes improved to $10.2 million. Net cash used in operating activities was $86.2 million versus $29.3 million a year earlier. Long-term debt (less current portion) increased to $2,299.4 million, and total liabilities exceeded total assets, leaving stockholders’ equity at $(1,043.2) million as of March 31, 2026.
Calumet, Inc. reported that board member Jennifer G. Straumins has decided not to stand for re-election and will retire from the Board at the end of her current term, which expires at the Company’s 2026 Annual Meeting of Stockholders.
The Company stated that her decision is not due to any disagreement with its operations, policies, or practices. Calumet issued a press release with additional background on her long association with the business and noted that the Board, through its Nominating and Governance Committee, will continue evaluating Board composition and skills to align with the Company’s strategy and governance practices.
Calumet, Inc. has completed a private placement of $150 million in additional 9.75% Senior Notes due 2031 through its subsidiaries Calumet Specialty Products Partners, L.P. and Calumet Finance Corp. The notes were sold at 105% of par, generating net proceeds of approximately $154.9 million.
The company intends to use these proceeds to repay borrowings outstanding under its revolving credit facility, effectively terming out a portion of its short-term debt into longer-dated senior notes. These Additional Notes form a single series with the existing $405 million of 9.75% Senior Notes due 2031, sharing the same terms other than initial offering price.
Calumet, Inc. announced that its subsidiaries agreed to sell $150 million aggregate principal amount of 9.75% Senior Notes due 2031 in a private offering under Rule 144A and Regulation S. The notes will be issued at 105% of par, generating approximately $154.9 million in net proceeds, which Calumet plans to use to repay borrowings under its revolving credit facility.
The new notes are an additional issuance to the existing $405 million of 9.75% Senior Notes due 2031, forming a single series with the same terms other than initial offering price. Calumet also executed a Tenth Amendment to its Third Amended and Restated Credit Agreement to permit this new indebtedness.
Calumet, Inc. has announced that its subsidiaries intend to privately issue $150 million of 9.75% Senior Notes due 2031 as a tack-on to existing notes. The new notes will form a single series with $405 million of the same 9.75% Senior Notes issued on January 12, 2026.
The company plans to use the net proceeds to repay borrowings under its revolving credit facility, effectively refinancing debt. The offering will be made to eligible purchasers under Rule 144A and Regulation S and the notes will not be registered under the Securities Act.
Calumet, Inc. reported fourth quarter and full-year 2025 results showing sharply improved profitability and major balance sheet actions. For 2025, sales were $4,137.1 million versus $4,189.4 million in 2024, while net loss narrowed to $33.8 million from $222.0 million. Adjusted EBITDA was $211.2 million and Adjusted EBITDA with Tax Attributes reached $293.3 million, helped by Clean Fuel Production Credits.
The Specialty Products and Solutions segment delivered 2025 Adjusted EBITDA of $291.8 million, up from $222.5 million, with higher adjusted gross profit per barrel. Performance Brands’ Adjusted EBITDA declined to $47.9 million, reflecting a divestiture and nonrecurring insurance proceeds, while Montana/Renewables posted segment Adjusted EBITDA of $(50.8) million but positive Adjusted EBITDA with Tax Attributes of $31.3 million.
Operating cash flow swung to an inflow of $108.9 million from an outflow of $46.4 million in 2024. Management highlighted about $100 million of structural cost reductions and paydown of $222 million of recourse debt. In January 2026, Calumet issued $405 million of 9.75% Senior Notes due 2031 and used proceeds, with cash and revolver borrowings, to redeem 2026 and 2027 notes, and extended its $500 million ABL facility to 2031.
Calumet, Inc. has amended its main credit facility through a Ninth Amendment to its Third Amended and Restated Credit Agreement. The change extends the facility’s maturity to January 23, 2031 and sets total lender commitments at $500.0 million, subject to borrowing base limitations.
The amendment also revises covenants, representations, warranties and events of default so the company or its subsidiaries can complete new inventory financing transactions once certain customary conditions are met. If any such inventory financing transaction occurs, total commitments under the credit agreement will be reduced from $500.0 million to $425.0 million.
Calumet, Inc. reported that subsidiaries Calumet Specialty Products Partners, L.P. and Calumet Finance Corp. issued $405.0 million of new 9.75% Senior Notes due 2031 in a private Rule 144A/Reg S offering. The notes were sold at 98.996% of par, generating approximately $393.0 million in net proceeds after discounts and expenses.
The company plans to use these proceeds, along with cash on hand and borrowings under its revolving credit facility, to redeem all outstanding 11.00% Senior Notes due 2026 and 8.125% Senior Notes due 2027, with redemptions expected on or before January 21, 2026. The new notes mature on February 15, 2031, pay interest semi-annually, carry senior unsecured guarantees from the parent and most subsidiaries, and include customary covenants, change-of-control repurchase rights at 101%, and specified call premiums starting in 2028.
Calumet, Inc. reported that its affiliates Calumet Specialty Products Partners, L.P. and Calumet Finance Corp. agreed to sell $405.0 million of 9.75% Senior Notes due 2031 in a private offering under Rule 144A and Regulation S. The notes will be issued at 98.996% of par, providing approximately $393.0 million in net proceeds after discounts and estimated expenses, and are expected to close on January 12, 2026, subject to customary conditions.
The company plans to use the net proceeds, along with cash on hand and borrowings under its revolving credit facility, to redeem all outstanding 11.00% Senior Notes due 2026 and 8.125% Senior Notes due 2027 on or before January 21, 2026, thereby addressing these upcoming debt maturities.
Calumet, Inc. announced that its wholly owned subsidiaries, Calumet Specialty Products Partners, L.P. and Calumet Finance Corp., intend to offer $350.0 million in aggregate principal amount of senior unsecured notes due 2031 in a private placement to eligible purchasers. Calumet plans to use the net proceeds from the new notes, together with cash on hand and borrowings under its revolving credit facility, to redeem all of its outstanding 11.00% Senior Notes due 2026 on or around January 21, 2026 and $275.0 million of its outstanding 8.125% Senior Notes due 2027 on or around January 16, 2026. The notes will not be registered under the Securities Act or state securities laws and may only be offered and sold in the United States pursuant to an applicable registration exemption.
Calumet, Inc. filed a current report noting that it has issued a press release with preliminary, unaudited information about its liquidity and select fiscal year 2025 financial results. The press release is attached as an exhibit to the report and is incorporated by reference. The company also clarifies that this preliminary financial and liquidity information is being furnished rather than filed, so it is not automatically subject to certain Exchange Act liabilities or included in other securities filings unless specifically cited.
Calumet, Inc. (CLMT) furnished quarterly results under Item 2.02. On November 7, 2025, the company reported results for the quarter ended September 30, 2025 via a press release, which is included as Exhibit 99.1.
Consistent with General Instruction B.2, the information is furnished, not filed, and is not subject to Section 18 liabilities. It will not be incorporated by reference into other filings unless expressly stated.
Calumet, Inc. (CLMT) announced non‑reliance on its unaudited interim financial statements for the periods ended March 31, 2025 and June 30, 2025, due to a cash flow classification error in the statements of cash flows. The company will restate those periods and file amended Quarterly Reports on Form 10‑Q.
The error misclassified amounts between operating and financing cash flows and had no impact on revenue, net income (loss), or cash and cash equivalents. For the three months ended March 31, 2025, operating cash flow is expected to improve by approximately $81.3 million to $29.3 million of net cash used, with financing cash flow reduced to $109.0 million provided. For the six months ended June 30, 2025, operating cash flow is expected to improve by approximately $76.9 million to $31.1 million of net cash used, with financing cash flow reduced to $111.6 million provided.
Management and the Audit Committee identified a material weakness in internal control over financial reporting related to cash flow statement preparation and review, and concluded disclosure controls and procedures for those periods were ineffective.
Calumet, Inc. filed a current report describing that it has released its financial results for the quarter ended June 30, 2025. On August 8, 2025, the company issued a press release with its results of operations and financial condition, which is furnished as Exhibit 99.1 to this report rather than being treated as formally filed. The report also notes inclusion of Exhibit 104, which contains the cover page interactive data file with XBRL tags embedded in the Inline XBRL document.
Calumet, Inc. (CLMT) filed an 8-K to disclose a $120 million sale-leaseback of its Shreveport refinery fuels terminal, truck rack and related equipment. Subsidiary Calumet Shreveport sold the assets to Stonebriar Commercial Finance and immediately leased them back under a seven-year Master Lease Agreement (Property Schedule No. 2).
- Monthly rent: ≈ $1.8 million, implying a 10.75% annual cost of capital.
- Early buy-out option: after six years for ≈ $42 million.
- The parent company reaffirmed its guaranty of all lease obligations.
- ≈ $40 million of proceeds were applied to retire obligations under the now-terminated 2021 Property Schedule No. 1.
Concurrent amendments were executed to accommodate the new indebtedness and liens:
- Eighth Amendment to the Third Amended & Restated Credit Agreement (Bank of America, N.A. agent).
- Third Amendment to the Monetization Master Agreement with J. Aron & Co.
The transaction creates a new direct financial obligation, adjusts existing credit facilities, and constitutes a disposition and re-acquisition of assets for accounting purposes. Exhibits, including a press release dated July 28 2025, will be filed with the next Form 10-Q.